Non-antimicrobial properties of tetracyclines - Dental and medical implications

West Indian Medical Journal

Volumn 50, Issue 2, 2001, Pages 105-108

  Rawal, S Y ^a   Rawal, Y B ^a  

^a UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORTETRACYCLINE; COLLAGEN; DOXYCYCLINE; MATRIX METALLOPROTEINASE; METACYCLINE; MINOCYCLINE; TETRACYCLINE DERIVATIVE;

ANGIOGENESIS; ANTIMICROBIAL ACTIVITY; BACTERIOSTASIS; BONE METABOLISM; CHEMICAL MODIFICATION; ENZYME INHIBITION; IMMUNE RESPONSE; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; PERIODONTAL DISEASE; REVIEW; STREPTOMYCES AUREOFACIENS;

ANTI-BACTERIAL AGENTS; HUMANS; MATRIX METALLOPROTEINASES; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOCLASTS; OSTEOGENESIS; PERIODONTITIS; TETRACYCLINES;

EID: 0034893149     PISSN: 00433144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Golub LM, Lee HM, Lehrer G, Nemiroff A, McNamara TF, Kaplan R et al. Minocycline reduces Gingival Collagenolytic activity during diabetes: preliminary observations and a proposed new mechanism of action. J Periodont Res 1983; 18: 516-26.
2. Reynolds JJ. Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation. Oral Dis, 1996; 2: 70-6.
3. Ryan ME, Ramamurthy NS, Golub LM. Matrix metalloproteinases and their inhibition in periodontal treatment. Curr Opin Periodontol 1996; 3: 85-96.
4. Rifkin BR, Vernillo AT, Golub LM. Blocking periodontal disease progression by inhibiting tissue destructive enzymes: a potential therapeutic role for tetracyclines and their chemically modified analogs: J Periodontol 1993; 64: 819-27.
5. Lee H, Golub LM, Suzuki K. Specificity of the anticollagenase action of tetracyclines. J Dent Res 1991; 70 (spec issue): 1621.
6. Sorsa T, Uitto VJ, Suomalainen K, Vauhkonen M, Lindy S. Comparison of interstitial collagenases from human gingiva, sulcular fluid and polymorphonuclear leukocytes. J Periodont Res 1988; 23: 386-93.
7. Halinen S, Sorsa T, Ding Y, Ingman T, Salo T, Konttinen YT et al: Characterization of matrix metalloproteinase (MMP-8 and -9) activities in the saliva and in gingival crevicular fluid of children with Down's Syndrome. J Periodontol 1996; 67: 748-54.
8. Athayde N, Edwin SS, Romero R, Gomez R, Maymon E, Pacora P et al. A role for matrix metalloproteinase in spontaneous rupture of fetal membranes. Am J Obstet Gynecol 1998; 179: 1248-53.
9. Vadillo-Ortega F, Hernandez A, Gonzalez-Avilla G, Bermejo L, Iwata K, Strauss JF 3rd. Increased matrix metalloproteinase activity and reduced inhibitor of metalloproteinases-1 levels in amniotic fluids from pregnancies complicated by premature rupture of membranes. Am J Obstet Gynecol 1996; 174: 1371-6.
10. Yager DR, Zhang LY, Liang HX, Diegelmann RF, Cohen IK. Wound fluid from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J Invest Dermatol 1996; 107: 743-8.
11. Crean JK, Roberts S, Jaffray DC, Eisenstein SM, Duance VC. Matrix metalloproteinases in the human intervertebral disc; role in disc degeneration and scoliosis: Spine 1997; 22: 2877-84.
12. Brown PD. Matrix metalloproteinase inhibitors in the treatment of cancer. Med Oncol 1997; 14: 1-10.
13. Kahari VM, Saarialho-Kere U. Matrix metalloproteinases in skin. Exp Dermatol 1997; 6: 199-213.
14. Sang QX. Complex role of matrix metalloproteinases in angiogenesis. Cell Res 1998; 8: 171-7.
15. Ryan ME, Greenwald RA, Golub LM. Potential of tetracyclines to modify cartilage breakdown in osteoarthritis. Curr Opin Rheumatol 1996; 8: 238-47.
16. de Bri E, Lei W, Svenson O, Chowdhury M, Moak SA, Greenwald RA. Effect of an inhibitor of matrix metalloproteinases on spontaneous osteoarthritis in guinea pigs. Adv Dent Res 1998; 12: 82-5.
17. Zernicke RF, Wohl GR, Greenwald RA, Moak SA, Leng W, Golub LM. Administration of systemic matrix metalloproteinase inhibitors maintains bone mechanical integrity in adjuvant arthritis. J Rheumatol 1997; 24: 1324-31.
18. Greenwald RA, Golub LM, Laveites B, Ramamurthy NS, Laskin R, Gruber B. Tetracyclines inhibit human synovial collagenases in vivo and in vitro. J Rheumatol 1987; 14: 28-32.
19. Golub LM, Ramamurthy NS, McNamara TF, Gomes B, Wolff M, Ciancio S et al. Tetracyclines inhibit tissue collagenase activity: a new mechanism in the treatment of periodontal disease. J Periodont Res 1984; 19: 651-5.
20. Golub LM, Wolff M, Lee HM, McNamara TF, Ramamurthy NS, Zambon J et al. Further evidence that Tetracyclines inhibit collagenase activity in human crevicular fluid and from other mammalian sources. J Periodont Res 1985; 20: 12-23.
21. Golub LM, McNamara TF, D'Angelo G, Greenwald R, Ramamurthy NS. A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity. J Dent Res 1987; 66: 1310-14.
22. SorsaT, Ramamurthy NS, Vernillo AT, Zhang X, Konttinen YT, Rifkin BR et al. Functional sites of chemically modified tetracyclines: inhibition of the oxidative activation of human neutrophil and chicken osteoclast pro-matrix metalloproteinases. J Rheumatol 1998; 25: 975-82.
23. Craig RG, Yu Z, Xu L, Barr R, Ramamurthy N, Boland J et al. A chemically modified tetracycline inhibits streptozocin induced diabetic depression of skin collagen synthesis and steady-state type I procollagen mRNA. Biochem Biophys Acta 1998; 1402: 250-60.
24. Karimbux NY, Ramamurthy NS, Golub LM, Nishimura I. The expression of collagen I and XII mRNAs in porphyromnas gingivalis induced periodontitis in rats; the effect of doxycycline and chemically modified tetracyclines. J Periodontol 1998; 69: 34-40.
25. Ramamurthy NS, Lee H, Vidal A, McNamara T, Rifkin BR, Golub LM. Effect of non-antimicrobial tetracycline on gingivitis and collagenase activity in ODU-rats. J Dent Res 1989; 68 (spec issue): 1840A.
26. Bouwsma O, Payonk G, Baron H and Sipos T. Low dose doxycycline: effects on clinical parameters in adult periodontitis. J Dent Res 1992; 71: (spec issue) AADR Abstract No. 1119.
27. Bouwsma O, Payonk G, Baron H and Sipos T. Low dose doxycycline reduces GCF collagenase in adult periodontitis. J Dent Res 1992; 71: (special issue) AADR Abstract No. 1120.
28. Golub LM, Ciancio S, Ramamurthy NS, Leung M and McNamara T. Low dose doxycycline therapy: effect on gingival and crevicular fluid collagenase in humans. J Periodont Res 1990; 25: 321-30.
29. Golub LM, Lee HM, Ryan ME. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res 1998; 12: 12-26.
30. Golub LM, Wolff M and Roberts S. Treating periodontal diseases by blocking tissue destructive enzymes. J Am Dent Assoc Vol 1994; 125: 163-9.
31. Klapisz-Wolikow M, Saffar JL. Minocycline impairment of both osteoid tissue removal and osteoclastic resorption in a synchronized model of remodel ing in the rat. J Cell Physiol 1996; 167: 359-68.
32. Ayoagi M, Sasaki T, Ramamurthy NS, Golub LM. Tetracycline/ flurbiprofen combination therapy modulates bone remodeling in ovariectomized rats: preliminary observations. Bone 1996; 19: 629-35.
33. Sasaki T, Ramamurthy NS, Golub LM. Long term therapy with a new chemically modified tetracycline (CMT-8) inhibits bone loss in femurs of ovariectomized rats. Adv Dent Res 1998; 12: 76-81.
34. Vernillo AT, Rifkin BR. Effects of tetracyclines on bone metabolism. Adv Dent Res 1998; 12: 56-62.
35. Ryan ME, Ramamurthy NS, Golub LM. Tetracyclines inhibit protein glycation in experimental diabetes. Adv Dent Res 1998; 12: 152-8.
36. Seftar RE, Sefter EA, De Larco JE, Kleiner DE, Leferson J, Stetler-Stevenson WG et al. Chemically modified tetracyclines inhibit human melanoma cell invasion and metastasis. Clin Exp Metastasis 1998; 16: 217-25.
37. Amin AR, Patel RN, Thakker GD, Lowenstein CJ, Attur MG, Abramson SB. Post-transcriptional regulation of inducible nitric oxide synthase mRNA in murine macrophages by doxycycline and chemically modified tetracyclines. FEBS Lett 1997; 410: 259-64.
38. Trachtman H., Futterwéit S, Greenwald R, Moak S, Singhal P, Franki N et al. Chemically modified tetracyclines inhibit inducible nitric oxide synthase expression and nitric oxide production in cultured rat mesangial cells. Biochem Biophys Res Commun 1996; 229: 243-8.
39. Hanemaaijer R, Visser H, Koolwijk P, Sorsa T, Salo T, Golub LM et al. Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells. Adv Dent Res 1998; 12: 114-8.